Page 4 - Read Online
P. 4

Journal of Cancer Metastasis and Treatment
               CONTENTS







               1           Long non-coding RNAs as key regulators of cancer metastasis
                            Pratirodh Koirala, De-Hong Zou, Yin-Yuan Mo
                            J Cancer Metastasis Treat 2016;2:1-10  http://dx.doi.org/10.4103/2394-4722.171829

               2           Roles of dysregulated Notch pathway and small DNA tumor viruses in cancer initiation and
                            progression
                            Anthony G. Clementz, Paola Rizzo, Fernanda Martini, Mauro Tognon
                            J Cancer Metastasis Treat 2016;2:11-23  http://dx.doi.org/10.4103/2394-4722.171982


               3           The farnesoid X receptor and colon cancer
                            Guofeng Xie, Jean-Pierre Raufman
                            J Cancer Metastasis Treat 2016;2:24-28  http://dx.doi.org/10.4103/2394-4722.164288


               4           Withaferin A targeting both cancer stem cells and metastatic cancer stem cells in the UP-LN1
                            carcinoma cell model
                            Lai-Lei Ting, Andy Shau-Bin Chou, Chin-Hsuan Hsieh, Shih-Chieh Hsiung, See-Tong Pang, Shuen-
                            Kuei Liao
                            J Cancer Metastasis Treat 2016;2:29-40  http://dx.doi.org/10.4103/2394-4722.172008


               5           Hepatocellular carcinoma presenting as rapidly growing sternal mass: an unusual presentation
                            Rahul S. Kulkarni, Asha S. Anand, Apurva A. Patel, Sandip A. Shah
                            J Cancer Metastasis Treat 2016;2:41-43  http://dx.doi.org/10.4103/2394-4722.169643

               6           Molecular and cellular aspects of extramedullary manifestations of acute myeloid leukemia
                            Javad Mohammadiasl, Abbas Khosravi, Mohammad Shahjahani, Shirin Azizidoost, Najmaldin Saki
                            J Cancer Metastasis Treat 2016;2:44-50  http://dx.doi.org/10.4103/2394-4722.167230


               7           What we have learned from urinary bladder cancer models
                            Carina Bernardo, Céu Costa, Carlos Palmeira, Rosário Pinto-Leite, Paula Oliveira, Rui Freitas,
                            Francisco Amado, Lúcio L. Santos
                            J Cancer Metastasis Treat 2016;2:51-58  http://dx.doi.org/10.4103/2394-4722.171279


               8           Prognostic factors and efficacy of GDP-R therapy in refractory/relapsed diffuse large B-cell
                            lymphomas not eligible for high-dose therapy
                            Francesco Ghio, Giulia Cervetti, Nadia Cecconi, Matteo Pelosini, Sara Galimberti, Riccardo Morganti,
                            Paola Ferrari, Andrea Nicolini, Mario Petrini
                            J Cancer Metastasis Treat 2016;2:59-63  http://dx.doi.org/10.4103/2394-4722.172291


               9           The therapeutic potential of duloxetine in prostate cancer-related fatigue
                            Rita De Sanctis, Alessandro Viganò
                            J Cancer Metastasis Treat 2016;2:64-66  http://dx.doi.org/10.4103/2394-4722.164646
   1   2   3   4   5   6   7   8   9